参考文献/References:
[1] Teupe C，Rosak C.Diabetic cardiomyopathy and diastolic heart failure-difficulties with relaxation[J].Diabetes Res Clin Pract，2012，97（2）：185-194.
[2] Zeng H，He X，Hou X，et al.Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomy-opathy via upregulation of sirtuin3[J].Am J Physiol Heart Circ Physiol，2014，306（4）：H585-597.
[3] 里宏晴，焦慧，马清华，等.Apelin-13对糖尿病大鼠心肌纤维化的影响[J].解放军医学院学报，2013，（6）：621-624.
[4] Falc?覿o-Pires I，Gon?觭alves N，Gavina C，et al.Correlation between plasma levels of apelin and myocardial hypertrophy in rats and humans：possible target for treatment?[J].Expert Opin Ther Targets，2010，14（3）：231-241.
[5] Siddiquee K，Hampton J，Khan S，et al.Apelin protects against angiotensin Ⅱ-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production[J].J Hypertens，2011，29（4）：724-731.
[6] Pchejetski D，Foussal C，Alfarano C，et al.Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1[J].Eur Heart J，2012，33（18）：2360-2369.
[7] Maya L，Villarreal FJ.Diagnostic approaches for diabetic car-diomyopathy and myocardial fibrosis[J].J Mol Cell Cardiol，2010，
48（3）： 524-529.
[8] Foussal C，Lairez O，Calise D，et al.Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy[J].FEBS Lett，2010，584（1）：2363-2370.
[9] Romacho T，S?觃nchez-Ferrer CF，Peiró C.Visfatin/Nampt：an adipo-
kine with cardiovascular impact[J].Mediators Inflamm，2013，
946427.
[10] Huang Q，Guo Y，Zeng H，et al.Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells[J].Endocr Res， 2011，36（3）：93-100.
[11] Yu XY，Qiao SB，Guan HS，et al.Effects of visfatin on proliferation and collagen synthesis in rat cardiac fibroblasts[J].Horm Metab Res，2010，42（7）：507-513.
[12] Adya R，Tan BK，Punn A，et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways：novel insights into visfatin-induced angiogenesis[J].Cardiovasc Res，2008，78（2）：356-365.
[13] Kang YS，Song HK，Lee MH，et al.Visfatin is upregulated in type-2 diabetic rats and targets renal cells[J].Kidney Int，2010，
78（2）：170-181.
[14] Yang R，Chang L，Liu S，et al.High glucose induces Rho/ROCK-dependent visfatin and type Ⅰ procollagen expression in rat primary cardiac fibroblasts[J].Mol Med Rep，2014，10（4）：1992-1998.
[15] Ouwens DM，Diamant M.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy[J].Arch Physiol Biochem，2007，113（2）：76-86.
[16] Zhang Q，Zhu L，Zheng M，et al.Changes of serum omentin-1 levels in normal subjects，type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults[J].Ann Endocrinol （Paris），2014，75（3）：171-175.
[17] Dobrin JS，Lebeche D.Diabetic cardiomyopathy：signaling defects and therapeutic approaches[J].Expert Rev Cardiovasc Ther，2010，
8（3）：373-391.
[18] Greulich S，Chen WJ，Maxhera B，et al.Cardioprotective proper-ties of omentin-1 in type 2 diabetes：evidence from clinical and in vitro studies[J].PLoS One，2013，8（3）：e59697.
[19] Yamawaki H，Kuramoto J，Kameshima S，et al.Omentin，a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells[J].Biochem Biophys Res Commun，2011，
408（12）：339-343.
[20] Zhong X，Li X，Liu F，et al.Omentin inhibits TNF-alpha-induced expression of adhesion molecules in endothelial cells via ERK/NF-kappaB pathway[J].Biochem Biophys Res Commun，2012，425（2）：401-406.
[21] Landgraf K，Friebe D，Ullrich T，et al.Chemerin as a mediator between obesity and vascular inflammation in children[J].J Clin Endocrinol Metab，2012，97（4）：E556-E564.
[22] Yamawaki H，Kameshima S，Usui T，et al.A novel adipocy-tokine，chemerin exerts anti-inflammatory roles in human vascular endothelial cells[J].Biochem Biophys Res Commun，2012，423（1）：152-157.
相似文献/References:
[1]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[2]刘美娟,朱惠娟,龚凤英.Glypican-，4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity，insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]